Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique;Doença pulmonar por Mycobacterium tuberculosis e mycobactérias não-tuberculosas entre pacientes recém- diagnosticados como HIV positivos em Moçambique, África

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 10, 2008, Pages 822-828

  Nunes, Elizabete Abrantes ^a   De Capitani, Eduardo Mello ^b,d   Coelho, Elizabete ^c   Panunto, Alessandra Costa ^b   Joaquim, Orvalho Augusto ^a   De Carvalho Ramos, Marcelo ^b  

^a EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c MAPUTO CENTRAL HOSPITAL   (Mozambique)

^d NONE   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Atypical; Drug resistance; HIV; Mozambique; Multiple; Mycobacteria; Tuberculosis

Indexed keywords

EID: 56449122800     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132008001000011     Document Type: Article

References (19)

1. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis. 1992;165(6): 1082-5.
2. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Incidence and natural history of Mycobacterium aviumcomplex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis. 1992;146(2):285-9.
3. Fordham von Reyn C, Arbeit RD, Tosteson AN, Ristola MA, Barber TW, Waddell R, et al. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group. AIDS. 1996;10(9):1025-32.
4. Yates MD, Pozniak A, Grange JM. Isolation of mycobacteria from patients seropositive for the human immunodeficiency virus (HIV) in south east England: 1984-92. Thorax. 1993;48(10):990-5.
5. Di Lonardo M, Isola NC, Ambroggi M, Rybko A, Poggi S. Mycobacteria in HIV-infected patients in Buenos Aires. Tuber Lung Dis. 1995;76(3): 185-9.
6. Aziz MA. Anti-tuberculosis drug resistance in the world: third global report : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 1999-2002. Geneva: World Health Organization, 2004.
7. Telenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31(2):175-8.
8. Niemann S, Harmsen D, Rüsch-Gerdes S, Richter E. Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA sequence polymorphism analysis. J Clin Microbiol. 2000;38(9):3231-4. 9. Mac-Arthur A, Gloyd S, Perdigão P, Noya A, Sacarlal J, Kreiss J. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique, lnt J Tuberc Lung Dis. 2001;5(10):894-902.
9. Dgedge M, Novoa A, Macassa G, Sacarlal J, Black J, Michaud C, et al. The burden of disease in Maputo City, Mozambique: registered and autopsied deaths in 1994. Bull World Health Organ. 2001;79(6):546-52.
10. Salomao MA. The National Tuberculosis Control Programme in Mozambique, 1985-1990. Bull lnt Union Tuberc Lung Dis. 1991;66(4):175-8.
11. Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beim Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis. 1997;25(2):242-6.
12. Vandercam B, Gala JL, Gerain J, Degraux J, Bourlond A, Colebunders B, et al. About two cases of Mycobacterium simiae infection in AIDS: review of the pathogenicity. Acta Clin Belg. 1998;53(3):206-12.
13. Al-Abdely HM, Revankar SG, Graybill R. Disseminated Mycobacterium simiae infection in patients with AIDS. J Infect. 2000;41(2):143-7.
14. Huminer D, Dux S, Samra Z, Kaufman L, Lavy A, Block CS, et al. Mycobacterium simiae infection in Israeli patients with AIDS. Clin Infect Dis. 1993;17(3):508-9.
15. Sampaio JL, Artiles N, Pereira RM, Souza JR, Leite JP. Mycobacterium simiae infection in a patient with acquired immunodeficiency syndrome. Braz J Infect Dis. 2001;5(6):352-5.
16. Tudó G, González J, Obama R, Rodriguez JM, Franco JR, Espasa M, et al. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology, lnt J Tuberc Lung Dis. 2004;8(1):15-22.
17. Bretzel G, Aziz M, Wendl-Richter U, Adatu F, Aisu T, van Wijnen A, et al. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. lnt J Tuberc Lung Dis. 1999;3(9):810-5.
18. Dosso M, Bonard D, Msellati P, Bamba A, Doulhourou C, Vincent V, et al. Primary resistance to antituberculosis drugs: a national survey conducted in Côte d'Ivoire in 1995-1996. lvoirian Study Group on Tuberculosis Resistance, Int J Tuberc Lung Dis. 1999;3(9):805-9.
19. Kritski A, Dalcolmo M, del Bianco R, del Melo FF, Pinto WP, Schechther M, et al. Association of tuberculosis and HIV infection in Brazil [Article in Portuguese]. Bol Oficina Sanit Panam. 1995;118(6):542-54.